Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia
Open Access
- 17 September 2026
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Abstract
1. Spironolactone, a synthetic steroidal antagonist of the mineralocorticoid receptor, was first synthesized in 1957 [1]. Since its introduction into clinical practice, it has become an essential t...Keywords
Funding Information
- Internal Grant Agency of the Tomas Bata Hospital
- Zlín Region (25-2-015)
This publication has 32 references indexed in Scilit:
- Pathophysiology, symptoms, outcomes, and evaluation of hyponatremia: comprehension and best clinical practiceClinical and Experimental Nephrology, 2025
- The renin angiotensin aldosterone systemPflügers Archiv - European Journal of Physiology, 2024
- Furosemide-associated hyponatremia in internal medicine patients: Analysis of epidemiological and biochemical profilesEuropean Journal of Internal Medicine, 2023
- Aldosterone Antagonist Dosing and the Risk of Hyponatremia in Patients With Cirrhosis and AscitesGastro Hep Advances, 2022
- Hyponatremia in CirrhosisClinics in Liver Disease, 2022
- Association between newly initiated thiazide diuretics and hospitalization due to hyponatremiaEuropean Journal of Clinical Pharmacology, 2021
- Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillationJournal of Clinical Laboratory Analysis, 2020
- Guidelines of care for the management of acne vulgarisJournal of the American Academy of Dermatology, 2016
- Blood Urea Nitrogen in the Early Assessment of Acute PancreatitisArchives of internal medicine (1960), 2011
- Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium HomeostasisHeart Failure Reviews, 2005